Single-Cell Genome Sequencing Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET INTRODUCTION

Single-cell genome sequencing includes the isolation of a single cell, to amplify as well as sequence the genes that are present within a single cell. The technique aims to enable a better understanding of complex microbial ecosystems and diseases in multicellular organisms. The use of single-cell genome sequencing is expected to increase significantly since they help in revealing molecular changes that play a vital role in carcinogenesis, interactions with the host immune system, and metastasis.

MARKET DYNAMICS

The single-cell genome sequencing (SCGS) market is anticipated to grow in the forecast, owing to the rising prevalence of chronic disease along with an increase in the number of autoimmune disorders. Also, favorable government policies and funding schemes are expected to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE

The "Global Single-Cell Genome Sequencing (SCGS) Market Analysis to 2031" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of single-cell genome sequencing (SCGS) market with detailed market segmentation by product, technology, workflow, disease indication, application, end user and geography. The global single-cell genome sequencing (SCGS) market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading single-cell genome sequencing (SCGS) market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global single-cell genome sequencing (SCGS) market is segmented on the basis of product, technology, workflow, disease indication, application, and end user. Based on product, the market is classified as, instruments and reagents. On the basis of technology, the market is categorized as, multiple displacement amplification (MDA), microarray, polymerase chain reaction (PCR), quantitative pcr (qPCR), and sequencing. The single-cell genome sequencing (SCGS) market based on workflow is categorized as, genomic analysis, sample preparation and single cell isolation. On the basis of disease indication, the market is segmented as, cancer, immunology, microbiology, neurobiology, prenatal diagnosis, and other diseases. The single-cell genome sequencing (SCGS) market is categorized based on application such as, cell differentiation/reprogramming, circulating cells, genomic variation, subpopulation characterization, and other applications. Similarly, on the basis of end user, the market is segmented as, academic & research laboratories, biotechnology & biopharmaceutical companies, clinics, and other end users.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global single-cell genome sequencing (SCGS) market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The single-cell genome sequencing (SCGS) market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting single-cell genome sequencing (SCGS) market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the single-cell genome sequencing (SCGS) market in these regions.

MARKET PLAYERS

The report covers key developments in the single-cell genome sequencing (SCGS) market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from single-cell genome sequencing (SCGS) market are anticipated to have lucrative growth opportunities in the future with the rising demand for single-cell genome sequencing (SCGS) market in the global market. Below mentioned is the list of few companies engaged in the single-cell genome sequencing (SCGS) market.

The report also includes the profiles of key single-cell genome sequencing (SCGS) market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

•  10x Genomics
•  BD
•  BGI
•  Bio-Rad Laboratories, Inc.
•  Fluidigm
•  Novogene Corporation
•  Oxford Nanopore Technologies
•  QIAGEN
•  Takara Bio Inc.
•  Thermo Fisher Scientific Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Single-Cell Genome Sequencing (SCGS) Report Scope